Abstract Cardiac amyloidosis (CA) is an infiltrative disease. In the present study, we compared the diagnostic accuracy of cardiovascular magnetic resonance (CMR)-based T1-mapping and subsequent extracellular volume fraction (ECV) measurement and longitudinal strain analysis in the same patients with (a) biopsy-proven cardiac amyloidosis (CA) and (b) hypertrophic cardiomyopathy (HCM). N = 30 patients with CA, N = 20 patients with HCM and N = 15 healthy control patients without relevant cardiac disease underwent dedicated CMR studies. The CMR protocol included standard sequences for cine-imaging, native and post-contrast T1-mapping and late-gadolinium-enhancement. ECV measurements were based on pre- and post-contrast T1-mapping images. Featu...
Background: Diagnosis of cardiac involvement in amyloid A (AA) amyloidosis is challenging since AA a...
Background:In-vivo cardiovascular magnetic resonance (CMR) diffusion tensor imaging (DTI) allows ima...
Cardiac amyloidosis (CA) is a rare and phenotypically heterogeneous disease, with pathophysiological...
Abstract Background Regional variability of longitudinal strain (LS) has been previously described w...
Late gadolinium enhancement imaging by cardiac magnetic resonance imaging (CMR) is the most reliable...
Background: Right ventricular (RV) strain has provided valuable prognostic information for patients ...
ObjectivesThis study sought to explore the potential role of noncontrast myocardial T1 mapping for d...
Abstract Cardiovascular magnetic resonance (CMR) plays an important clinical role for diagnosis and ...
Objectives: This study sought to explore the potential role of noncontrast myocardial T1 mapping for...
OBJECTIVES: This study sought to explore the potential role of noncontrast myocardial T1 mapping for...
ObjectivesThis study tested the diagnostic and prognostic utility of a rapid, visual T1 assessment m...
ObjectivesWe sought to evaluate the diagnostic performance of cardiovascular magnetic resonance imag...
Cardiac involvement is the leading cause of death in patients with cardiac amyloidosis. Early recogn...
Early diagnosis is crucial for the improvement of outcomes of patients with cardiac amyloidosis (CA)...
AIMS: To assess the prognostic value of myocardial pre-contrast T1 and extracellular volume (ECV) in...
Background: Diagnosis of cardiac involvement in amyloid A (AA) amyloidosis is challenging since AA a...
Background:In-vivo cardiovascular magnetic resonance (CMR) diffusion tensor imaging (DTI) allows ima...
Cardiac amyloidosis (CA) is a rare and phenotypically heterogeneous disease, with pathophysiological...
Abstract Background Regional variability of longitudinal strain (LS) has been previously described w...
Late gadolinium enhancement imaging by cardiac magnetic resonance imaging (CMR) is the most reliable...
Background: Right ventricular (RV) strain has provided valuable prognostic information for patients ...
ObjectivesThis study sought to explore the potential role of noncontrast myocardial T1 mapping for d...
Abstract Cardiovascular magnetic resonance (CMR) plays an important clinical role for diagnosis and ...
Objectives: This study sought to explore the potential role of noncontrast myocardial T1 mapping for...
OBJECTIVES: This study sought to explore the potential role of noncontrast myocardial T1 mapping for...
ObjectivesThis study tested the diagnostic and prognostic utility of a rapid, visual T1 assessment m...
ObjectivesWe sought to evaluate the diagnostic performance of cardiovascular magnetic resonance imag...
Cardiac involvement is the leading cause of death in patients with cardiac amyloidosis. Early recogn...
Early diagnosis is crucial for the improvement of outcomes of patients with cardiac amyloidosis (CA)...
AIMS: To assess the prognostic value of myocardial pre-contrast T1 and extracellular volume (ECV) in...
Background: Diagnosis of cardiac involvement in amyloid A (AA) amyloidosis is challenging since AA a...
Background:In-vivo cardiovascular magnetic resonance (CMR) diffusion tensor imaging (DTI) allows ima...
Cardiac amyloidosis (CA) is a rare and phenotypically heterogeneous disease, with pathophysiological...